skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
gp100:209-217(210M) Peptide Vaccine (Code C49022)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: gp100:209-217(210M) Peptide Vaccine

Definition: A synthetic peptide cancer vaccine consisting of amino acid residues 209 through 217 of the glycoprotein 100 (gp100) melanoma antigen, with a methionine substitution at position 210 designed to improve immunogenicity. Vaccination with gp100:209-217(210M) peptide may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells expressing gp100.

Display Name: gp100:209-217(210M) Peptide Vaccine

Label: gp100:209-217(210M) Peptide Vaccine

NCI Thesaurus Code: C49022 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0672448  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
G9 209-2M
gp100:209-217(210M) Peptide Vaccine

External Source Codes: 
NSC Code 683472 (see NCI DTP info)
PDQ Closed Trial Search ID 476335
PDQ Open Trial Search ID 476335 (check for NCI PDQ open clinical trial info)
UMLS CUI C0672448

Other Properties:
     Name Value (qualifiers indented underneath)
code C49022
Contributing_Source CTRP
Legacy_Concept_Name gp100_209-217_210M
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom